KORNITZER CAPITAL MANAGEMENT INC /KS - HALOZYME THERAPEUTICS INC ownership

HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 357 filers reported holding HALOZYME THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.48 and the average weighting 0.2%.

Quarter-by-quarter ownership
KORNITZER CAPITAL MANAGEMENT INC /KS ownership history of HALOZYME THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$17,248,217
+12.0%
451,524
+5.8%
0.36%
+17.5%
Q2 2023$15,394,460
-5.0%
426,794
+0.6%
0.30%
-6.2%
Q1 2023$16,199,969
-6.8%
424,194
+38.9%
0.32%
-8.2%
Q4 2022$17,374,358
-1.9%
305,349
-31.8%
0.35%
-7.4%
Q3 2022$17,711,000
-10.2%
447,914
-0.0%
0.38%
-3.6%
Q2 2022$19,713,000
-9.6%
448,014
-18.1%
0.39%
+9.7%
Q1 2022$21,803,000
-0.8%
546,7150.0%0.36%
+9.5%
Q4 2021$21,983,000
+16.2%
546,715
+17.6%
0.33%
+13.1%
Q3 2021$18,913,000
-10.4%
464,9300.0%0.29%
-8.5%
Q2 2021$21,112,000
+23.0%
464,930
+12.9%
0.32%
+15.3%
Q1 2021$17,164,000
-2.4%
411,6950.0%0.28%
-7.7%
Q4 2020$17,583,000
+44.7%
411,695
-10.9%
0.30%
+25.2%
Q3 2020$12,149,000
-3.0%
462,300
-1.1%
0.24%
-5.9%
Q2 2020$12,527,000
+47.9%
467,265
-0.7%
0.25%
+25.9%
Q1 2020$8,469,000
+79.0%
470,750
+76.4%
0.20%
+139.3%
Q4 2019$4,732,000266,8950.08%
Other shareholders
HALOZYME THERAPEUTICS INC shareholders Q3 2022
NameSharesValueWeighting ↓
Third Security, LLC 7,048,282$126,799,00027.23%
First Light Asset Management, LLC 1,630,591$29,334,0005.01%
SNYDER CAPITAL MANAGEMENT L P 3,393,057$61,041,0003.48%
Bellevue Group AG 7,663,956$137,874,0002.67%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 307,633$5,531,0002.52%
Lombard Odier Asset Management (Switzerland) SA 900,000$16,191,0002.17%
Elk Creek Partners, LLC 654,362$11,772,0002.02%
DOHENY ASSET MANAGEMENT /CA 127,110$2,254,0001.79%
Granite Investment Partners, LLC 1,277,438$22,981,0001.49%
Amia Capital LLP 69,409$1,249,0001.11%
View complete list of HALOZYME THERAPEUTICS INC shareholders